Atossa Genetics: Potential Breakthrough in Breast Cancer?
Biopharmaceutical company Atossa Genetics receives Buy rating from H.C. Wainwright, with a new price target of $4.00. The company's promising ...
- Latest
- Trending
Biopharmaceutical company Atossa Genetics receives Buy rating from H.C. Wainwright, with a new price target of $4.00. The company's promising ...
Goldman Sachs reaffirms Buy rating on ASML Holding NV, expects strong growth in 2025. ASML's impressive order intake and competitive ...
Diamondback Energy and Endeavor Energy Resources are set to merge in a $26 billion deal, creating a dominant player in ...
India's top IT companies are set to benefit as customers phase out legacy applications. With their expertise in modernization and ...
Citi initiates coverage on Palmer Square Capital BDC with a Buy rating and $17.00 price target, expressing confidence in the ...
The highly anticipated Bollywood romance "Teri Baaton Mein Aisa Uljha Jiya" is set to make its debut on Amazon Prime ...
French President Macron appoints Gerard Mestrallet as special envoy to rival China's Belt and Road initiative with a major railway ...
Citi raises price target for Frontier Group Holdings Inc. as airline shows improved operational performance, but remains cautious due to ...
Luxury shoemaker Tod's saw a 17.4% increase in shares after receiving an acquisition bid from L Catterton. The bid, supported ...
The Dell G16 gaming laptop is currently on sale at Amazon, with a $400 discount off its original price. This ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.